Please login to the form below

Not currently logged in

personalised medicine

This page shows the latest personalised medicine news and features for those working in and with pharma, biotech and healthcare.

NICE plans to widen the net for data it uses in guidance

NICE plans to widen the net for data it uses in guidance

That update is intended to take into account developments such as personalised medicine, digitisation of health and use of cell and gene therapy.

Latest news

More from news
Approximately 12 fully matching, plus 108 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 6 fully matching, plus 36 partially matching documents found.

Latest appointments

  • BMS appoints new commercial leader, Davies joins Eisai and more BMS appoints new commercial leader, Davies joins Eisai and more

    The field of genomic medicine has the potential to revolutionise our approach to rare genetic disease diagnosis and management, as well as in other areas of personalised medicine.”.

  • Stephen Eck joins Aravive Biologics Stephen Eck joins Aravive Biologics

    chairman of the board of directors of the Personalised Medicine Coalition.

  • FlowMetric Diagnostics names president FlowMetric Diagnostics names president

    It is a great time for the development of new flow cytometry-based companion diagnostics which can help advance personalised medicine and better meet the needs of physicians, healthcare workers and

  • GlobalData makes Americas appointment GlobalData makes Americas appointment

    Dr Bonnie Bain, global head of healthcare at GlobalData, adds: “Sean is widely recognised as an expert and thought leader in personalised and translational medicine, and it's great to welcome

  • Roche appoints new oncology research head Roche appoints new oncology research head

    Personalised cancer has been his forte, however, and he has served as director of personalised cancer medicine at Vanderbilt. ... I was particularly attracted to Roche as one of the pioneers and front-runners in personalised medicine, as the world's top

More from appointments
Approximately 0 fully matching, plus 8 partially matching documents found.

Latest from PMHub

  • In the precision medicine era, the line between products and services is blurred

    Personalised and precision medicine, however, can offer specialised treatments that target the patient’s unique cancer subtype, its genetic mutations, and the affected tissues. ... Optimising the service behind the personalised and precision medicine

  • Making a difference with patient support

    Empowering the patient. Providing a stepping-stone to personalised medicine. Reassuring HCPs that the treatment is a both viable option for the patient and that it is adequately supported.

  • Perspective: the patient edition

    The ALS patient journey. An article on CAR-T service design. Thought provoking content on clinical trial access and the social determinants of healthcare, and on precision and personalised medicine.

  • Spotlight interview: 15 minutes on Independent Medical Education

    By looking at futuristic things that are already impacting healthcare for example artificial intelligence, and personalised medicine, , we have a real opportunity for IME to make an impact on both medical ... There will be many more “small group” or

  • Five key trends in precision and personalised healthcare

    Here, we deep dive into five of the key trends in precision medicine and personalised healthcare to explore how the healthcare industry is changing and how pharmaceutical and biotech companies can ... Innovative pricing models in precision and

More from PMHub
Approximately 4 fully matching, plus 26 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs


Add my company
Syneos Health®

Syneos Health® (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization. The Company, including a Contract Research Organization (CRO) and...

Latest intelligence

Diversity in clinical trials: looking back at our 2021 blogs
In this blog, we look back at the Innovative Trials' Equality & Diversity (E&D) committee blogs across 2021...
What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
Securing a future for telehealth with immersive market research insights...